Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 9 of 191
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Basilea, iNtRON sign deal for antibacterial agent

Next year, Basilea will explore multiple hypotheses through preclinical studies to identify the optimal future clinical development programme for tonabacase. Under an exclusive option, Basilea will license tonabacase